Literature DB >> 26860222

EPO induces changes in synaptic transmission and plasticity in the dentate gyrus of rats.

William Almaguer-Melian1, Daymara Mercerón-Martínez2, Susana Delgado-Ocaña2, Nancy Pavón-Fuentes1, Nuris Ledón3, Jorge A Bergado1.   

Abstract

Erythropoietin has shown wide physiological effects on the central nervous system in animal models of disease, and in healthy animals. We have recently shown that systemic EPO administration 15 min, but not 5 h, after daily training in a water maze is able to induce the recovery of spatial memory in fimbria-fornix chronic-lesioned animals, suggesting that acute EPO triggers mechanisms which can modulate the active neural plasticity mechanism involved in spatial memory acquisition in lesioned animals. Additionally, this EPO effect is accompanied by the up-regulation of plasticity-related early genes. More remarkably, this time-dependent effects on learning recovery could signify that EPO in nerve system modulate specific living-cellular processes. In the present article, we focus on the question if EPO could modulate the induction of long-term synaptic plasticity like LTP and LTD, which presumably could support our previous published data. Our results show that acute EPO peripheral administration 15 min before the induction of synaptic plasticity is able to increase the magnitude of the LTP (more prominent in PSA than fEPSP-Slope) to facilitate the induction of LTD, and to protect LTP from depotentiation. These findings showing that EPO modulates in vivo synaptic plasticity sustain the assumption that EPO can act not only as a neuroprotective substance, but is also able to modulate transient neural plasticity mechanisms and therefore to promote the recovery of nerve function after an established chronic brain lesion. According to these results, EPO could be use as a molecular tool for neurorestaurative treatments.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  EPO; LTD; LTP; neural plasticity; synaptic plasticity

Mesh:

Substances:

Year:  2016        PMID: 26860222     DOI: 10.1002/syn.21895

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  5 in total

1.  Is erythropoietin a worthy candidate for traumatic brain injury or are we heading the wrong way?

Authors:  Giovanni Grasso; Concetta Alafaci; Pietro Ghezzi
Journal:  F1000Res       Date:  2016-05-19

2.  Pre-Treatment with Erythropoietin Attenuates Bilateral Renal Ischemia-Induced Cognitive Impairments.

Authors:  Mahshid Tahamtan; Vahid Sheibani; Seyed Mostafa Shid Moosavi; Majid Asadi-Shekaari; Saeed Esmaeili-Mahani; Iraj Aghaei; Mohammad Shabani
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

3.  Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial.

Authors:  Lejla Sjanic Schmidt; Jeff Zarp Petersen; Maj Vinberg; Ida Hageman; Niels Vidiendal Olsen; Lars Vedel Kessing; Martin Balslev Jørgensen; Kamilla Woznica Miskowiak
Journal:  Trials       Date:  2018-04-19       Impact factor: 2.279

Review 4.  Current Evidence on the Protective Effects of Recombinant Human Erythropoietin and Its Molecular Variants against Pathological Hallmarks of Alzheimer's Disease.

Authors:  José J Jarero-Basulto; Martha C Rivera-Cervantes; Deisy Gasca-Martínez; Francisco García-Sierra; Yadira Gasca-Martínez; Carlos Beas-Zárate
Journal:  Pharmaceuticals (Basel)       Date:  2020-11-26

5.  Contradictory effects of erythropoietin on inhibitory synaptic transmission in left and right prelimbic cortex of mice.

Authors:  Andre Dik; Roja Saffari; Mingyue Zhang; Weiqi Zhang
Journal:  Neurobiol Stress       Date:  2018-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.